Company profile
Home - Sonrai Analytics
Sonrai Analytics is the leading AI Data Discovery solution for Biomarker Discovery, Development and Deployment.
Financial period: 1 Apr 2024 to 31 Mar 2025
Reference milestones and recent Companies House filing stream events.
Next confirmation statement due date
Next accounts due date
Last confirmation statement made up date
Last accounts made up date
Company registered at Companies House
Sonrai Analytics develops software specialising in data analytics and management.
Sonrai Analytics Ltd was developed based on a commercial need highlighted by an industry partner. Sonrai Analytics's software platform is designed to meet the demands of both precision analytics and reproducible data findings of important legacy. It offers bespoke healthcare analytical frameworks supporting AI.
None yet
Sonrai Analytics have secured VC investment of £700,000, as well as an Innovate UK award for the ACTIONED (integrAted moleCular soluTIons fOr diagNostics and Early Detection) Consortium, facilitating collaboration between Sonrai, QUB's PMC and Roche in a partnership valued at over £7M. With a focus on colorectal cancer, this award is enabling Sonrai to establish technology and software relating to genomics and tissue-based cancer diagnostics in PMC's state-of-the-art accredited laboratory, while capitalising on Roche's position as the leading global provider of diagnostic solutions in cancer genomics and tissue diagnostics. More recently, Sonrai Analytics have secured an Artificial Intelligence in Health and Care Award (£2.2M) to deliver novel AI cancer screenings across the NHS in partnership with the PMC. Their AI screening method is potentially a transformational diagnostic tool, delivering more accurate testing and faster results for patients who have had lung and colorectal biopsies, potentially saving the NHS millions each year.
1 Nov 2024 to 31 Oct 2029
**The Northern Ireland Precision Biomarkers and Therapeutics Consortium (NIPBT)** is a partnership of Life and Health Science (LHS) companies and Academia, aligned to the strategies of both the Departments of Health and Economy of the NI devolved government to enhance health and wealth creation for NI citizens. Currently, NI has a significant presence in ...
1 Feb 2020 to 30 Apr 2023
ACTIONED (integrAted moleCular soluTIons fOr diagNostics and Early Detection) in a consortium of three main partners: 1.National leading experts in genomics/tissue-based cancer diagnostics (The Precision Medicine Centre of Excellence at Queen's University Belfast or PMC) 2.The leading global provider of diagnostic solutions in cancer genomics and tissue d...
1 Jan 2019 to 31 Mar 2023
"PathLEAD (**Path**ology data **L**akes, **E**ducation, **A**nalytics and **D**iscovery) is a consortium of nationally leading experts from the teaching hospitals of Coventry, Belfast, Nottingham and Oxford, their associated Universities and Philips, the commercial partner. We will develop computer aided diagnostics for testing of pathology samples. Speci...
